BioNTech authorizes $1 billion share repurchase program
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/15/2026
- Wall Street rallies, Dow ends with record on US-Iran deal, oil price slide
- Fox to acquire Roku for $22 billion to create streaming and live content giant
- SpaceX extends gains premarket after biggest IPO ever values it at $2.1 trillion
- These 2 space stocks were upgraded at KeyBanc today
- Nvidia plans to raise at least $20 billion in bond sale
- Brixmor Property Group announces passing of former CEO James Taylor
- Wall Street rallies, Dow ends with record on US-Iran deal, oil price slide
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- This stock is the biggest winner from higher voltages in the Datacenter IT room
- Johnson & Johnson shows positive results for TALVEY-DARZALEX drug combination
BioNTech Announces New ADS Repurchase Program
May 7, 2026 6:45 AM EDTMAINZ, Germany, May 7, 2026 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, BioNTech or the Company) today announced that it has authorized a new share repurchase program (the Program), under which the Company may repurchase American Depositary Shares (ADSs), each representing one ordinary share of the Company, for an aggregate amount of up to $1.0 billion. Repurchases under the Program may be made until and including May 6, 2027. BioNTechs disciplined... More
